ClinXus is a non-profit community based alliance established in West Michigan to enable biomarker driven and innovative clinical trial designs as recently defined by the United States Food and Drug Administration (FDA) and European regulatory agencies. The alliance is comprised of existing community health care, clinical, research, and educational organizations. It seeks to establish a 21st Century “open-architecture” biomarker driven clinical trials network to serve the increasingly molecular-based medical applications. The ClinXus network is dedicated to improvement of the clinical trial process by applying solutions and services related to innovative patient access, biomarker implementation and trial designs.
Coupled with the strengths and expertise of the organizations involved ClinXus acts as the single point of contact to extend the following coordinated community capabilities and services:
Protocol and project design, development and implementation
State of the art patient facilities and support
Extensive molecular profiling capability
Full breadth of integrated IT infrastructure

